Celcuity projects $2B revenue potential for gedatolisib in second-line breast cancer market
Discover Celcuity's Q4 2024 insights: gedatolisib's promising trials for breast cancer, $2B market potential, and key 2025 milestones.
iHeart on MSN12h
Over 200,000 Kids Jewelry-Making Kits Recalled Due To Hazardous Substances
The kits were sold at major retailers like Target, Marshall's, TJ Maxx, and Joann, as well as online at Amazon, Target, ...
Leap Therapeutics (LPTX) Conference Call to discuss Updated Data from Part B of the DeFianCe Study Transcript
Conference Call to discuss Updated Data from Part B of the DeFianCe Study March 26, 2025 8:00 AM ET. Company Participants. Douglas Onsi - President ...
More than 224K kids’ jewelry-making kits recalled over chemical hazard
LaRose Industries issued a recall for 224,100 Cra-Z-Art Gemex/Gel2Gem jewelry-making kits after learning that resin in the kits contained a hazardous amount of acrylate.